Bone marrow stromal cells from multiple myeloma patients uniquely induce bortezomib resistant NF-κB activity in myeloma cells
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1476-4598
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Bone marrow stromal cells from multiple myeloma patients uniquely induce bortezomib resistant NF-κB activity in myeloma cells ; volume:9 ; number:1 ; day:6 ; month:7 ; year:2010 ; pages:1-13 ; date:12.2010
Molecular cancer ; 9, Heft 1 (6.7.2010), 1-13, 12.2010
- Urheber
-
Markovina, Stephanie
Callander, Natalie S.
O'Connor, Shelby L.
Xu, Guangwu
Shi, Yufang
Leith, Catherine P.
Kim, KyungMann
Trivedi, Parul
Kim, Jaehyup
Hematti, Peiman
Miyamoto, Shigeki
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1186/1476-4598-9-176
- URN
-
urn:nbn:de:101:1-2021082806264472550507
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
- 14.08.2025, 10:59 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Markovina, Stephanie
- Callander, Natalie S.
- O'Connor, Shelby L.
- Xu, Guangwu
- Shi, Yufang
- Leith, Catherine P.
- Kim, KyungMann
- Trivedi, Parul
- Kim, Jaehyup
- Hematti, Peiman
- Miyamoto, Shigeki
- SpringerLink (Online service)
Ähnliche Objekte (12)
New bortezomib-based combination therapy for elimination of myeloma cells
Pirh2 mediates the sensitivity of myeloma cells to bortezomib via canonical NF-κB signaling pathway
Glycogen Synthase Kinase-3 regulates multiple myeloma cell growth and bortezomib-induced cell death
Microbial antigens-loaded myeloma cells enhance Th2 cell proliferation and myeloma clonogenicity via Th2–myeloma cell interaction
Establishment of a bortezomib-resistant Chinese human multiple myeloma cell line: MMLAL
Metformin and FTY720 Synergistically Induce Apoptosis in Multiple Myeloma Cells
Lenalidomide vs bortezomib maintenance choice post-autologous hematopoietic cell transplantation for multiple myeloma
Lenalidomide versus bortezomib maintenance after frontline autologous stem cell transplantation for multiple myeloma
Lenalidomide versus bortezomib maintenance after frontline autologous stem cell transplantation for multiple myeloma
Bortezomib, lenalidomide, and dexamethasone (VRd) followed by autologous stem cell transplant for multiple myeloma
A feline case of multiple myeloma treated with bortezomib
YL064 directly inhibits STAT3 activity to induce apoptosis of multiple myeloma cells
New bortezomib-based combination therapy for elimination of myeloma cells
Pirh2 mediates the sensitivity of myeloma cells to bortezomib via canonical NF-κB signaling pathway
Glycogen Synthase Kinase-3 regulates multiple myeloma cell growth and bortezomib-induced cell death
Microbial antigens-loaded myeloma cells enhance Th2 cell proliferation and myeloma clonogenicity via Th2–myeloma cell interaction
Establishment of a bortezomib-resistant Chinese human multiple myeloma cell line: MMLAL
Metformin and FTY720 Synergistically Induce Apoptosis in Multiple Myeloma Cells
Lenalidomide vs bortezomib maintenance choice post-autologous hematopoietic cell transplantation for multiple myeloma
Lenalidomide versus bortezomib maintenance after frontline autologous stem cell transplantation for multiple myeloma
Lenalidomide versus bortezomib maintenance after frontline autologous stem cell transplantation for multiple myeloma
Bortezomib, lenalidomide, and dexamethasone (VRd) followed by autologous stem cell transplant for multiple myeloma
A feline case of multiple myeloma treated with bortezomib
YL064 directly inhibits STAT3 activity to induce apoptosis of multiple myeloma cells
New bortezomib-based combination therapy for elimination of myeloma cells
Pirh2 mediates the sensitivity of myeloma cells to bortezomib via canonical NF-κB signaling pathway
Glycogen Synthase Kinase-3 regulates multiple myeloma cell growth and bortezomib-induced cell death
Microbial antigens-loaded myeloma cells enhance Th2 cell proliferation and myeloma clonogenicity via Th2–myeloma cell interaction
Establishment of a bortezomib-resistant Chinese human multiple myeloma cell line: MMLAL
Metformin and FTY720 Synergistically Induce Apoptosis in Multiple Myeloma Cells
Lenalidomide vs bortezomib maintenance choice post-autologous hematopoietic cell transplantation for multiple myeloma
Lenalidomide versus bortezomib maintenance after frontline autologous stem cell transplantation for multiple myeloma
Lenalidomide versus bortezomib maintenance after frontline autologous stem cell transplantation for multiple myeloma
Bortezomib, lenalidomide, and dexamethasone (VRd) followed by autologous stem cell transplant for multiple myeloma
A feline case of multiple myeloma treated with bortezomib